ICICI Prudential Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
ICICI Prudential Asset Management's BIIB Position: Q1 2026 in Review
ICICI Prudential Asset Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 9,462 shares — an estimated $1.67M sold.
ICICI Prudential Asset Management first reported a position in BIIB in Q4 2016 and held it in 25 quarters. The position peaked at $9.67M in Q3 2022. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- ICICI Prudential Asset Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
- ICICI Prudential Asset Management sold 9,462 Biogen shares in Q1 2026, an estimated $1.67M.
- ICICI Prudential Asset Management first reported a position in Biogen in Q4 2016 and held it in 25 quarters.
- ICICI Prudential Asset Management's Biogen position peaked at $9.67M in Q3 2022.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on ICICI Prudential Asset Management's 13F filing for Q1 2026, filed 11 May 2026.